Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 117

The DOI matches its Crossref record.

Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections

Gilchrist, Samuel E., Lange, Dirk, Letchford, Kevin, Bach, Horacio, Fazli, Ladan, Burt, Helen M.·2013·Journal of Controlled Release

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2013.04.012

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 56

  1. Elek, 1957, The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection, Br. J. Exp. Pathol., 38, 573
  2. Rand, 1993, Alternatives to reimplantation for salvage of the total knee arthroplasty complicated by infection, J. Bone Joint Surg. Am., 75, 282, 10.2106/00004623-199302000-00018 · doi:10.2106/00004623-199302000-00018
  3. Segawa, 1999, Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections, J. Bone Joint Surg. Am., 81, 1434, 10.2106/00004623-199910000-00008 · DOI · Paper page
  4. Giulieri, 2004, Management of infection associated with total hip arthroplasty according to a treatment algorithm, Infection, 32, 222, 10.1007/s15010-004-4020-1 · DOI · Paper page
  5. Mader, 1993, Antimicrobial treatment of osteomyelitis, Clin. Orthop. Relat. Res., 87
  6. Hanssen, 2004, Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements, Clin. Orthop. Relat. Res., 427, 79, 10.1097/01.blo.0000143806.72379.7d · doi:10.1097/01.blo.0000143806.72379.7d
  7. Ambrose, 2004, Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model, Clin. Orthop. Relat. Res., 293, 10.1097/01.blo.0000126303.41711.a2 · DOI
  8. Kanellakopoulou, 2000, Carrier systems for the local delivery of antibiotics in bone infections, Drugs, 59, 1223, 10.2165/00003495-200059060-00003 · DOI · Paper page
  9. Baker, 1988, Release of gentamicin from acrylic bone cement. Elution and diffusion studies, J. Bone Joint Surg. Am., 70, 1551, 10.2106/00004623-198870100-00015 · DOI · Paper page
  10. Levin, 1975, The effectiveness of various antibiotics in methyl methacrylate, J. Bone Joint Surg. Br., 57, 234, 10.1302/0301-620X.57B2.234 · DOI
  11. Mader, 1997, In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads, Antimicrob. Agents Chemother., 41, 415, 10.1128/AAC.41.2.415 · doi:10.1128/aac.41.2.415
  12. van de Belt, 2000, Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release, Biomaterials, 21, 1981, 10.1016/S0142-9612(00)00082-X · DOI · Paper page
  13. Kendall, 1996, Persistence of bacteria on antibiotic loaded acrylic depots. A reason for caution, Clin. Orthop. Relat. Res., 273, 10.1097/00003086-199608000-00034 · doi:10.1097/00003086-199608000-00034
  14. Berman, 1984, Thermally induced bone necrosis in rabbits. Relation to implant failure in humans, Clin. Orthop. Relat. Res., 284
  15. Campoccia, 2006, The significance of infection related to orthopedic devices and issues of antibiotic resistance, Biomaterials, 27, 2331, 10.1016/j.biomaterials.2005.11.044 · DOI · Paper page
  16. Yang, 2009, PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections, Pharm. Res., 26, 1644, 10.1007/s11095-009-9875-5 · DOI
  17. You, 2005, In vitro degradation behavior of electrospun polyglycolide, polylactide, and poly(lactide-co-glycolide), J. Appl. Polym. Sci., 95, 193, 10.1002/app.21116 · DOI · Paper page
  18. Reneker, 1996, Nanometre diameter fibers of polymer, produced by electrospinning, Nanotechnology, 7, 216, 10.1088/0957-4484/7/3/009 · DOI · Paper page
  19. Reneker, 2000, Bending instability of electrically charged liquid jets of polymer solutions in electrospinning, J. Appl. Phys., 87, 4531, 10.1063/1.373532 · DOI · Paper page
  20. Boland, 2004, Electrospinning collagen and elastin: preliminary vascular tissue engineering, Front. Biosci., 9, 1422, 10.2741/1313 · DOI · Paper page
  21. Yoshimoto, 2003, A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering, Biomaterials, 24, 2077, 10.1016/S0142-9612(02)00635-X · DOI · Paper page
  22. Yang, 2005, Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering, Biomaterials, 26, 2603, 10.1016/j.biomaterials.2004.06.051 · DOI · Paper page
  23. Sahoo, 2006, Characterization of a novel polymeric scaffold for potential application in tendon/ligament tissue engineering, Tissue Eng., 12, 91, 10.1089/ten.2006.12.91 · DOI · Paper page
  24. Katti, 2004, Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters, J. Biomed. Mater. Res. B Appl. Biomater., 70, 286, 10.1002/jbm.b.30041 · DOI · Paper page
  25. Zeng, 2003, Biodegradable electrospun fibers for drug delivery, J. Control. Release, 92, 227, 10.1016/S0168-3659(03)00372-9 · DOI · Paper page
  26. Torres-Giner, 2012, Controlled Delivery of Gentamicin Antibiotic from Bioactive Electrospun Polylactide-Based Ultrathin Fibers, Adv. Eng. Mater., 14, 10.1002/adem.201180006 · DOI
  27. Said, 2012, Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing, Eur. J. Pharm. Biopharm., 80, 85, 10.1016/j.ejpb.2011.08.007 · DOI
  28. Said, 2011, Antimicrobial PLGA ultrafine fibers: interaction with wound bacteria, Eur. J. Pharm. Biopharm., 79, 108, 10.1016/j.ejpb.2011.03.002 · DOI
  29. Weber, 1983, High-pressure liquid chromatographic quantitation of rifampin and its two major metabolites in urine and serum, Rev. Infect. Dis., 5, S433, 10.1093/clinids/5.Supplement_3.S433 · doi:10.1093/clinids/5.supplement_3.s433
  30. McFarland, 1907, The nephelometer: an instrument for estimating the number of bacteria in suspension used for calculating the opsonic index and for vaccines, JAMA, XLIX, 1176, 10.1001/jama.1907.25320140022001f · DOI · Paper page
  31. Chakraborty, 2009, Electrohydrodynamics: a facile technique to fabricate drug delivery systems, Adv. Drug Deliv. Rev., 61, 1043, 10.1016/j.addr.2009.07.013 · DOI · Paper page
  32. Xie, 2006, Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro, Pharm. Res., 23, 1817, 10.1007/s11095-006-9036-z · DOI · Paper page
  33. Farber, 1986, Interaction between rifampin and fusidic acid against methicillin-resistant coagulase-positive and -negative staphylococci, Antimicrob. Agents Chemother., 30, 174, 10.1128/AAC.30.1.174 · doi:10.1128/aac.30.1.174
  34. Xu, 2008, The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning, Eur. J. Pharm. Biopharm., 70, 165, 10.1016/j.ejpb.2008.03.010 · DOI · Paper page
  35. Perlroth, 2008, Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature, Arch. Intern. Med., 168, 805, 10.1001/archinte.168.8.805 · DOI · Paper page
  36. Regar, 2001, Stent development and local drug delivery, Br. Med. Bull., 59, 227, 10.1093/bmb/59.1.227 · DOI · Paper page
  37. Ravivarapu, 2000, Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate, J. Pharm. Sci., 89, 732, 10.1002/(SICI)1520-6017(200006)89:6<732::AID-JPS4>3.0.CO;2-D · doi:10.1002/(sici)1520-6017(200006)89:6<732::aid-jps4>3.0.co;2-d
  38. Taepaiboon, 2007, Vitamin-loaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin E, Eur. J. Pharm. Biopharm., 67, 387, 10.1016/j.ejpb.2007.03.018 · DOI · Paper page
  39. Fong, 1999, Beaded nanofibers formed during electrospinning, Polymer, 40, 4585, 10.1016/S0032-3861(99)00068-3 · DOI · Paper page
  40. Verreck, 2003, Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer, J. Control. Release, 92, 349, 10.1016/S0168-3659(03)00342-0 · DOI · Paper page
  41. Cui, 2006, Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetamol inoculation, Biomacromolecules, 7, 1623, 10.1021/bm060057z · DOI · Paper page
  42. Srikar, 2008, Desorption-limited mechanism of release from polymer nanofibers, Langmuir, 24, 965, 10.1021/la702449k · DOI · Paper page
  43. Carey, 1971, Micellar properties of sodium fusidate, a steroid antibiotic structurally resembling the bile salts, J. Lipid Res., 12, 604, 10.1016/S0022-2275(20)39480-3 · doi:10.1016/s0022-2275(20)39480-3
  44. Li, 2009, Distribution of Sorbitan Monooleate in poly(l-lactide-co-varepsilon-caprolactone) nanofibers from emulsion electrospinning, Colloids Surf., B Biointerfaces, 69, 221, 10.1016/j.colsurfb.2008.11.031 · doi:10.1016/j.colsurfb.2008.11.031
  45. Owen, 2010, An in vitro study of plasticized poly(lactic-co-glycolic acid) films as possible guided tissue regeneration membranes: material properties and drug release kinetics, J. Biomed. Mater. Res. A, 95, 857, 10.1002/jbm.a.32865 · DOI
  46. Jackson, 2004, Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel, Int. J. Pharm., 283, 97, 10.1016/j.ijpharm.2004.06.025 · DOI
  47. Puppi, 2010, Poly(lactic-co-glycolic acid) electrospun fibrous meshes for the controlled release of retinoic acid, Acta Biomater., 6, 1258, 10.1016/j.actbio.2009.08.015 · DOI
  48. Toma, 1995, Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci, J. Clin. Microbiol., 33, 1712, 10.1128/JCM.33.7.1712-1715.1995 · DOI
  49. Drugeon, 1994, In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus, J. Antimicrob. Chemother., 34, 899, 10.1093/jac/34.6.899 · DOI
  50. Grohs, 2003, In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus, Antimicrob. Agents Chemother., 47, 418, 10.1128/AAC.47.1.418-420.2003 · DOI
  51. McCabe, 1968, Comparison of the antibacterial activity of rifampicin and other antibiotics, Am. J. Med. Sci., 256, 255, 10.1097/00000441-196810000-00007 · doi:10.1097/00000441-196810000-00007
  52. Soriano, 2005, In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis, Rev. Esp. Quimioter., 18, 168
  53. Prabhakara, 2011, Murine immune response to a chronic Staphylococcus aureus biofilm infection, Infect. Immun., 79, 1789, 10.1128/IAI.01386-10 · DOI
  54. Kotb, 1995, Bacterial pyrogenic exotoxins as superantigens, Clin. Microbiol. Rev., 8, 411, 10.1128/CMR.8.3.411 · DOI · Paper page
  55. Chau, 2009, Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome, Nat. Med., 15, 641, 10.1038/nm.1965 · DOI
  56. Feezor, 2003, Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria, Infect. Immun., 71, 5803, 10.1128/IAI.71.10.5803-5813.2003 · DOI · Paper page

Cited by

See all 117

Metadata

Authors
Gilchrist, S. E., Lange, D., Letchford, K., Bach, H., Fazli, L., & Burt, H. M.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2013-08
Volume
170
Issue
1
Pages
64-73
ISSN
0168-3659
Cited by
117
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Canadian Foundation for Innovation (CFI)
  • Natural Sciences and Engineering Research Council (NSERC)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. https://app.cochat.ai/papers/10.1016/j.jconrel.2013.04.012
The paper
Gilchrist, S. E., Lange, D., Letchford, K., Bach, H., Fazli, L., & Burt, H. M. (2013). Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2013.04.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.